HYDRO B 1020 Burow’s Solution & Hydrocortisone

HYDRO B 1020 Burow’s Solution & Hydrocortisone

Drug Labeling and Warnings

Drug Details

k">

HYRO B 1020- burows solution and hydrocortisone liquid 
Henry Schein

Disclaimer: This drug has not been found by FDA to be safe and effective, and this labeling has not been approved by FDA. For further information about unapproved drugs, click here.

----------

HYDRO B 1020
Burow’s Solution & Hydrocortisone

For relief of inflammatory pruritic conditions in dogs

For Animal Use Only
Keep Out of Reach of Children

Indications:

A topical treatment for the relief of inflammatory pruritic conditions in dogs.

Hydrocortisone provides antiinflammatory and anti-pruritic activity, while Burow’s Solution is an astringent for drying of moist dermatitis while providing cooling relief of discomfort.

Dosage:

Apply 3 to 4 times daily.

Precautions:

For topical use only. Not intended for deep-seated infections. Not for use in the eyes.

Ingredients:

Each mL contains:
hydrocortisone.....................10 mg
burow’s solution...................20 mg

In a water miscible base containing propylene glycol.

Contraindication:

As with any topical hydrocortisone product, Hydro B 1020 should not be used in the presence of tuberculosis of the skin.

Storage:

Store at controlled room temperature between 15°-30°C (59°-86°F). Keep container tightly closed when not in use.

image of eye clock

Net Contents:

1 fl oz (30 mL) Reorder No. 003574

2 fl oz (60 mL) Reorder No. 005612

16 fl oz (473 mL) Reorder #003605  AH-003605-01 Rev. 0418

Questions? (855) 724-3461


Distributed by:
Henry Schein Animal Health
Dublin, OH 43017
www.henryscheinvet.com


Manufactured by:
First Priority, Inc.
Elgin, IL 60123

1 fl oz (30 mL)

image of LBHSTP100_iss0114

2 fl oz (60 mL)

image of LBHSTP101_iss0114

16 fl oz

image of LBHSTP103_iss0114

HYRO B 1020 
burows solution and hydrocortisone liquid
Product Information
Product TypeOTC ANIMAL DRUGItem Code (Source)NDC: 11695-2205
Route of AdministrationTOPICAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
HYDROCORTISONE (UNII: WI4X0X7BPJ) (HYDROCORTISONE - UNII:WI4X0X7BPJ) HYDROCORTISONE1.02 mg  in 1 mL
ALUMINUM ACETATE (UNII: 80EHD8I43D) (ALUMINUM CATION - UNII:3XHB1D032B) ALUMINUM ACETATE0.073 mg  in 1 mL
ACETIC ACID (UNII: Q40Q9N063P) (ACETIC ACID - UNII:Q40Q9N063P) ACETIC ACID0.0624 mg  in 1 mL
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC: 11695-2205-112 in 1 CASE
130 mL in 1 BOTTLE, DROPPER
2NDC: 11695-2205-212 in 1 CASE
260 mL in 1 BOTTLE, DROPPER
3NDC: 11695-2205-612 in 1 CASE
3473 mL in 1 BOTTLE, SPRAY
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
unapproved drug other01/01/2014
Labeler - Henry Schein (603750329)
Establishment
NameAddressID/FEIBusiness Operations
FIRST PRIORITY INCORPORATED179925722manufacture, label

Revised: 11/2018
 
Henry Schein


© 2020 FDA.report
This site is not affiliated with or endorsed by the FDA.